Catalent
CTLT
#1819
Rank
โ‚น1.081 T
Marketcap
โ‚น5,956
Share price
0.00%
Change (1 day)
20.46%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

EPS for Catalent (CTLT)

EPS in 2023 (TTM): -โ‚น105.67

According to Catalent's latest financial reports the company's current EPS (TTM) is -โ‚น593.96. In 2022 the company made an earnings per share (EPS) of โ‚น213.00 a decrease over its 2021 EPS that were of โ‚น306.83.

EPS history for Catalent from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-โ‚น105.67-149.61%
2022โ‚น213.00-30.58%
2021โ‚น306.8379.67%
2020โ‚น170.78114.12%
2019โ‚น79.76-15%
2018โ‚น93.8375.44%
2017โ‚น53.48-22.97%
2016โ‚น69.44-59.56%
2015โ‚น171.71282.05%
2014โ‚น44.94-378.2%
2013-โ‚น16.16

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Supernus Pharmaceuticals
SUPN
-โ‚น180.16-69.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Jazz Pharmaceuticals
JAZZ
โ‚น1,431-340.92%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Aerie Pharmaceuticals
AERI
-โ‚น70.37-88.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Intercept Pharmaceuticals
ICPT
-โ‚น138.87-76.62%๐Ÿ‡บ๐Ÿ‡ธ USA